| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
23.52 |
% |
10.6019/CHEMBL4513141 |
| Bacteroides fragilis |
Bacteroides fragilis |
MIC |
800.0 |
nM |
10.1021/acs.jmedchem.7b00143 |
| Candida albicans |
Candida albicans |
Inhibition |
2.15 |
% |
10.6019/CHEMBL4513141 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-1.25 |
% |
10.6019/CHEMBL4513141 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
0.28 |
ug.mL-1 |
10.1016/j.bmcl.2019.126642 |
| Escherichia coli |
Escherichia coli |
Inhibition |
5.05 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Potency |
15848.9 |
nM |
None |
| Giardia |
Giardia |
Potency |
1155.4 |
nM |
None |
| Giardia |
Giardia |
Potency |
14689.2 |
nM |
None |
| Giardia intestinalis |
Giardia intestinalis |
Efficacy |
92.0 |
% |
10.1021/acs.jmedchem.7b00143 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
259.3 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-9.77 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-5.54 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10593.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
14.36 |
% |
10.6019/CHEMBL4513141 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
135970.0 |
nM |
10.6019/CHEMBL3392926 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
9.89 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Rattus norvegicus |
Amount excreted |
11.7 |
% |
10.1021/jm00154a021 |
| Rattus norvegicus |
Rattus norvegicus |
Amount excreted |
13.2 |
% |
10.1021/jm00154a021 |
| Rattus norvegicus |
Rattus norvegicus |
Amount excreted |
29.6 |
% |
10.1021/jm00154a021 |
| Rattus norvegicus |
Rattus norvegicus |
Amount excreted |
36.9 |
% |
10.1021/jm00154a021 |
| Rattus norvegicus |
Rattus norvegicus |
Amount excreted |
42.1 |
% |
10.1021/jm00154a021 |
| Rattus norvegicus |
Rattus norvegicus |
Biliary excretion |
1.68 |
% |
10.1021/jm00385a027 |
| Rattus norvegicus |
Rattus norvegicus |
Biliary excretion |
7.33 |
% |
10.1021/jm00385a027 |
| Rattus norvegicus |
Rattus norvegicus |
Biliary excretion |
10.58 |
% |
10.1021/jm00385a027 |
| Rattus norvegicus |
Rattus norvegicus |
Biliary excretion |
12.32 |
% |
10.1021/jm00385a027 |
| Rattus norvegicus |
Rattus norvegicus |
Biliary excretion |
13.52 |
% |
10.1021/jm00385a027 |
| Rattus norvegicus |
Rattus norvegicus |
Biliary excretion |
14.72 |
% |
10.1021/jm00385a027 |
| Rattus norvegicus |
Rattus norvegicus |
Log BR |
2.068 |
None |
10.1021/jm00154a021 |
| Rattus norvegicus |
Rattus norvegicus |
Log BR |
2.121 |
None |
10.1021/jm00154a021 |
| Rattus norvegicus |
Rattus norvegicus |
Log BR |
2.471 |
None |
10.1021/jm00154a021 |
| Rattus norvegicus |
Rattus norvegicus |
Log BR |
2.567 |
None |
10.1021/jm00154a021 |
| Rattus norvegicus |
Rattus norvegicus |
Log BR |
2.625 |
None |
10.1021/jm00154a021 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
17.05 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1218 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-7.18 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.15 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.06305 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
10.83 |
% |
10.6019/CHEMBL4513141 |
| Trichophyton tonsurans |
Trichophyton tonsurans |
MIC |
0.8 |
ug.mL-1 |
10.1016/j.bmc.2012.04.045 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
25930.0 |
nM |
10.6019/CHEMBL3392926 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
130080.0 |
nM |
10.6019/CHEMBL3392926 |
| None |
ADMET |
Log k' |
0.199 |
None |
10.1021/jm00154a021 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
135970.0 |
nM |
10.6019/CHEMBL3392926 |
| None |
NON-PROTEIN TARGET |
IC50 |
407910.0 |
nM |
10.6019/CHEMBL3392926 |
| None |
No relevant target |
LogP |
0.6 |
None |
10.1021/jm00154a021 |
| None |
No relevant target |
LogP |
0.6 |
None |
10.1021/jm00385a027 |
| None |
Unchecked |
Ac50 |
8.913 |
uM |
None |
| None |
Unchecked |
AC50 |
8912.5 |
nM |
None |
| None |
Unchecked |
Hepatotoxicity (acute) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |